ChemoCentryx Inc news

   Watch this stock
Showing stories 1 - 10 of about 79   

Articles published

CCXI 4.49 -0.19 (-4.06%)
price chart
ChemoCentryx, Inc. (NASDAQ:CCXI) Dividend Yield Is N/A%
The technical analysis of ChemoCentryx, Inc. (NASDAQ:CCXI) highlights the stock is $-0.07 points away -1.49% from 50-day MA of $4.56.
CHEMOCENTRYX INC. (NASDAQ:CCXI) Financial Condition Compared to S&P 500
ChemoCentryx Inc. (NASDAQ:CCXI) has a Return on Assets of -36.43%. To compare, the S&P 500 oscillates between 1% and 4%.
ChemoCentryx, Inc. (NASDAQ:CCXI) Stock Momentum at Critical Inflection Point
This is a momentum stock rating analysis for ChemoCentryx, Inc. (NASDAQ:CCXI) . The company has a three bull momentum rating which indicates an inflection point.
Top Biotechnology Stock Picking: ChemoCentryx, Inc. (CCXI), TG Therapeutics ...
ChemoCentryx, Inc. (CCXI) ended last trading session with a change of -9.94 percent. It trades at an average volume of 1.33M shares versus 1.34M shares recorded at the end of last trading session.
Buzz Stocks: Infoblox Inc, Allergan plc Ordinary Shares, and ChemoCentryx Inc
U.S. stocks are higher today, as traders look to new earnings reports and improving oil prices. Among equities in focus today are network solutions provider Infoblox Inc (NYSE:BLOX), as well as pharmaceutical stocks Allergan plc Ordinary Shares ...
ChemoCentryx Inc. (CCXI) Drops 7.98% on June 01
ChemoCentryx Inc. (CCXI) was one of the Russell 2000's biggest losers for Wednesday June 01 as the stock slid 7.98% to $4.96, a loss of $-0.43 per share.
ChemoCentryx Inc. (CCXI) Jumps 6.3% on June 06
ChemoCentryx Inc. (CCXI) was among the biggest gainers on the Russell 2000 for Monday June 06 as the stock popped 6.3% to $5.40, representing a gain of $0.32 per share.
Stock in the Spotlight: ChemoCentryx, Inc. (NASDAQ:CCXI)
ChemoCentryx, Inc. (NASDAQ:CCXI) reported earnings for the three months ended March 2016 on May 10, 2016. The company earned $-0.34 per share on revenue of $0M.
Biotech Stock That is Just so Hot: ChemoCentryx Inc (NASDAQ:CCXI)
Share of ChemoCentryx Inc (NASDAQ:CCXI) traded on 47.83 percent above secure line at 12:11PM EDT in order to take the company's stock at the price of $4.44.
Vifor Pharma Licenses Rights to Commercialize ChemoCentryx's Orally ...  GlobeNewswire (press release)
Biotech stocks for your portfolio: ChemoCentryx Inc (NASDAQ:CCXI), StemCells ...  Zergwatch
Insider Buying Activity to Watch: ChemoCentryx Inc (NASDAQ:CCXI)
ChemoCentryx Inc (NASDAQ:CCXI) insiders have most recently took part in a trading activity. On 5/16/2016 Edwards Thomas A, Director bought 25,000 shares having total worth of $101,213 at the price of $4.05 per share, following the transaction a total ...
Chemocentryx, Inc. (CCXI) Files Form 4 Insider Buying : Thomas A. Edwards ...  Market Digest
A Director at ChemoCentryx (NASDAQ: CCXI) is Buying Shares  Analyst Ratings